Analysts’ New Coverage for April 27th (BMRN, CELC, CVLT, DHC, GRDN, HMH, HURA, KOPN, MATX, MU)

Analysts’ new coverage for Monday, April 27th:

Morgan Stanley started coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). The firm issued an overweight rating and a $120.00 price target on the stock.

Citizens Jmp initiated coverage on shares of Celcuity (NASDAQ:CELC). Citizens Jmp issued a market outperform rating and a $150.00 price target on the stock.

Jefferies Financial Group Inc. started coverage on shares of CommVault Systems (NASDAQ:CVLT). They issued a hold rating and a $105.00 price target on the stock.

Maxim Group began coverage on shares of Diversified Healthcare Trust (NASDAQ:DHC). They issued a buy rating and a $9.50 target price on the stock.

Bank of America Corporation began coverage on shares of Guardian Pharmacy Services (NYSE:GRDN). They issued a buy rating and a $42.00 price target on the stock.

Pickering Energy Partners began coverage on shares of HMH (NASDAQ:HMH). They issued an outperform rating on the stock.

JPMorgan Chase & Co. initiated coverage on shares of HMH (NASDAQ:HMH). JPMorgan Chase & Co. issued an overweight rating and a $26.00 target price on the stock.

Citizens Jmp began coverage on shares of TuHURA Biosciences (NASDAQ:HURA). They issued a market outperform rating and a $9.00 target price on the stock.

JonesTrading began coverage on shares of Kopin (NASDAQ:KOPN). JonesTrading issued a buy rating and a $6.00 price target on the stock.

JPMorgan Chase & Co. started coverage on shares of Matson (NYSE:MATX). They issued an overweight rating and a $230.00 price target on the stock.

Melius Research started coverage on shares of Micron Technology (NASDAQ:MU). Melius Research issued a buy rating and a $700.00 target price on the stock.

HC Wainwright assumed coverage on shares of NervGen Pharma (NASDAQ:NGEN). They issued a buy rating and a $18.00 price target on the stock.

Tigress Financial started coverage on shares of Oklo (NYSE:OKLO). Tigress Financial issued a buy rating and a $130.00 target price on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Powell Industries (NASDAQ:POWL). The firm issued an overweight rating and a $310.00 target price on the stock.

Alliance Global Partners initiated coverage on shares of Quantum eMotion (NYSEAMERICAN:QNC). They issued a buy rating and a $5.00 target price on the stock.

Melius Research began coverage on shares of Sandisk (NASDAQ:SNDK). Melius Research issued a buy rating on the stock.

Craig Hallum assumed coverage on shares of Spruce Biosciences (NASDAQ:SPRB). Craig Hallum issued a buy rating and a $140.00 target price on the stock.

Cantor Fitzgerald assumed coverage on shares of Shattuck Labs (NASDAQ:STTK). Cantor Fitzgerald issued an overweight rating on the stock.

Receive News & Ratings for BioMarin Pharmaceutical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioMarin Pharmaceutical Inc and related companies with MarketBeat.com's FREE daily email newsletter.